These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 3124536
1. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis. Meyrier A, Simon P. Adv Nephrol Necker Hosp; 1988; 17():127-50. PubMed ID: 3124536 [Abstract] [Full Text] [Related]
2. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea. Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ. Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521 [Abstract] [Full Text] [Related]
3. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults. Ponticelli C, Passerini P. Clin Nephrol; 1991 Jun; 35 Suppl 1():S16-21. PubMed ID: 1860261 [Abstract] [Full Text] [Related]
4. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature. Peters HP, van de Kar NC, Wetzels JF. Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266 [Abstract] [Full Text] [Related]
5. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis. Ittel TH, Clasen W, Fuhs M, Kindler J, Mihatsch MJ, Sieberth HG. Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831 [Abstract] [Full Text] [Related]
7. Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology. Meyrier A, Condamin MC, Broneer D. Clin Nephrol; 1991 Sep; 35 Suppl 1():S37-42. PubMed ID: 1860266 [Abstract] [Full Text] [Related]
8. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M. Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303 [Abstract] [Full Text] [Related]
9. Cyclosporine in idiopathic nephrotic syndrome. Ponticelli C. Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973 [Abstract] [Full Text] [Related]
11. Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome. Clin Nephrol; 1991 Aug; 35 Suppl 1():S48-60. PubMed ID: 1860268 [Abstract] [Full Text] [Related]
12. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients. Schena FP. J Nephrol; 1999 Aug; 12 Suppl 2():S125-30. PubMed ID: 10688412 [Abstract] [Full Text] [Related]
13. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis. Dumoulin A, Hill GS, Montseny JJ, Meyrier A. Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220 [Abstract] [Full Text] [Related]
14. [Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis]. Klinger M, Szewczyk Z. Przegl Lek; 1989 Jan; 46(10):744-9. PubMed ID: 2687950 [No Abstract] [Full Text] [Related]
19. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis. Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M. Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265 [Abstract] [Full Text] [Related]
20. The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN). Brodehl J, Krohn HP, Ehrich JH. Klin Padiatr; 1982 Apr; 194(3):162-5. PubMed ID: 6752557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]